ModelEdge

Moonlake Immunotherapeutics
MLTX
Filing TypeS-3ASR
Filing Date8/9/2026
Updated8/10/26, 2:37 PM

Filing

S-3ASR
Earnings Release

Exhibits

S-3ASRS-3ASR
EX-1.3AMENDMENT NO. 1 TO SALES AGREEMENT, BY AND BETWEEN MOONLAKE IMMUNOTHERAPEUTICS AND LEERINK PARTNERS LLC, DATED AUGUST 10, 2026
EX-4.1FORM OF INDENTURE FOR SENIOR DEBT SECURITIES AND THE RELATED FORM OF SENIOR DEBT SECURITY
EX-4.2FORM OF INDENTURE FOR SUBORDINATED DEBT SECURITIES AND RELATED FORM OF SUBORDINATED DEBT SECURITY
EX-5.1OPINION OF WALKERS (CAYMAN) LLP
EX-5.2OPINION OF WALKERS (CAYMAN) LLP
EX-23.1CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-FILING FEESFILING FEE TABLE
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic